Table 2. Interrupted time-series+difference-in-differences mixed Poisson model (IRR, 95% CI).
| Term | IRR | 95% CI | P value |
|---|---|---|---|
| Post (level change, February 2023) | 1.35 | 1.15 to 1.59 | 0.0003 |
| Post-trend (time_after, per month) | 0.93 | 0.89 to 0.98 | 0.002 |
| Earthquake area – colchicine_available versus outside (baseline) | 1.04 | 0.73 to 1.50 | 0.820 |
| Earthquake area – colchicine_unavailable versus outside (baseline) | 1.23 | 0.83 to 1.81 | 0.300 |
| Post×colchicine_available (extra level change) | 1.60 | 1.07 to 2.39 | 0.022 |
| Post×colchicine_unavailable (extra level change) | 2.64 | 1.97 to 3.53 | <0.001 |
| Post-trend×colchicine_available (extra monthly change) | 0.93 | 0.84 to 1.03 | 0.150 |
| Post-trend×colchicine_unavailable (extra monthly change) | 0.89 | 0.83 to 0.96 | 0.002 |
| Age ≥12 years (vs <12 years) | 1.09 | 0.94 to 1.26 | 0.270 |
| Age at diagnosis (per year) | 0.97 | 0.90 to 1.04 | 0.410 |
| Sex (female vs male) | 1.17 | 1.04 to 1.33 | 0.012 |
| Comorbidity_no_drug (vs none) | 1.33 | 1.05 to 1.68 | 0.020 |
| Comorbidity_with_drug use (vs none) | 1.24 | 0.97 to 1.58 | 0.086 |
| Mutation class 2 (vs 1) | 1.18 | 1.02 to 1.37 | 0.030 |
| Mutation class 3 (vs 1) | 1.00 | 0.73 to 1.39 | 0.980 |
| Mutation class 4 (vs 1) | 0.78 | 0.58 to 1.04 | 0.092 |
| Mutation class 5 (vs 1) | 1.00 | 0.81 to 1.23 | 1.00 |
Model fit and random effects: AIC=15 946; random-intercept SD (centre)=0.47, SD (ID)=0.82; random-slope (time_after) SD=0.106, corr=−0.74. Dispersion test p=0.17 (no over-dispersion); zero-inflation p=0.23.
Statistically significant IRR values are shown in bold (p < 0.05).
IRR, incidence rate ratio.